Education:
Ph.D., Dept. of Biological Systems Engineering, University of Wisconsin-Madison
MS, Biological Engineering, University of Missouri-Columbia
EMBA, Business Administration, National Taiwan University
Work and Academic Experience:
President, TCM Biotech International Corp. (4/2014-present)
EVP/CSO, TCM Biotech International Corp. (6/2003-3/2014)
Experience: Taiwan Executive Program, (GE program, 2009)
Taiwan TFDA, US FDA, Mainland China CFDA New Drug IND
Director of ITDP grant
Clinical trial conducting and coordination
Strategy partnering development
Establishment of fermentation manufactory
Establishment of R&D center
R&D Director, PhytoHealth Corporation (4/1999-11/2002)
Experience: New drug development
First Botanical Investigational New Drug (IND) approval from TFDA
Pre-clinical study (Chemistry, Manufacture and Control (CMC), Pharmacology, Pharmacokenitic, Toxicity)
New product/technology evaluation
IPO in Taiwan stock exchange
Company value evaluation
SBU Manager, United Biotech Corporation (10/1998-11/2002)
Experience: Chinese new drug development
Dietary supplement, Healthy Food development
Post Doctor, University of Wisconsin-Madison
Selected Presentations and Publication:
1996~2019 total 31 patents, Presentations and Publication articles
Wang, Y-C., Cell-free junctional DNA fragment from hepatitis B virus integration in HCC for monitoring post-resection recurrence and clonaltiy, 2019 ASCO annual meeting, Chicago, US.